![]() Torrent Pharmaceuticals Limited is notifying its distributors and customers by phone and in writing to immediately discontinue distribution of the specific lots being recalled and to notify their sub-accounts. Losartan potassium tablets, USP were distributed nationwide to Torrent’s wholesale distributor, repackager and retail customers. LOSARTAN POTASSIUM TAB, USP 25mg,90count bottles LOSARTAN POTASSIUM TAB, USP 50mg,90count bottles LOSARTAN POTASSIUM TAB, USP 50mg,30count bottles LOSARTAN POTASSIUM TAB, USP 100mg,90count bottles LOSARTAN POTASSIUM TAB, USP 100mg,30count bottles The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing these products. The products subject to recall are listed below and packaged in bottles. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication. Patients who are on Losartan should continue taking their medication, as the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment. ![]() Losartan is used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and for the treatment of nephropathy in Type 2 diabetic patients. To date, Torrent Pharmaceuticals Limited has not received any reports of adverse events related to this recall. NDEA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification. Torrent is only recalling lots of losartan-containing products that contain N-nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA. Torrent Pharmaceuticals Limited is expanding its voluntary recall from 2 lots of Losartan potassium tablets USP to a total of 10 lots, to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |